Autobio Diagnostics Co., Ltd.

¥39.76As of Sun 8 Nov 2026, 12:00 UTC
SSE:603658Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 0.84%
Div yield 3.29%
ROE 11.86%
Medical Devices
Beta (5Y) (0.05)
PE TTM 21.49
TSR TTM 7.58%
Mkt cap ¥22.72B
ROIC 14.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥43
7.15%
(2.93%)
Hold 3|10|1|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.57
0.55
0.54
0.57
11.37%
3.72%
2.21%
12.25%
Revenue¥B
2.015
1.997
1.997
2.006
11.36%
7.34%
2.04%
(0.35%)
Peers (US$3.406B)
Cap (US$)
PE
3.421B
—
3.409B
35.62x
Capital
TTM
5Y
10Y
Leveragex
1.055
0.870
0.729
EBIT/Intx
1.893
0.167
0.177
Own earn%
(12.15)
(9.20)
(4.25)
Sh yield%
43.06
25.41
26.95
Owners
Insiders/Inst%
11.78
25.98
Short interest%
1.73
SBC / revenue%
5.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
19–23
$1 testx
0.3
Incr. ROIC%
11